Revive Med
ReviveMed has pioneered AI-driven technology that can measure metabolite masses quickly and inexpensively, with the goal of finding more efficient and effective ways to explore the complex field of metabolomics (the study of sets of metabolites present in cells and tissue.) With a better understanding of metabolites and how they interact with drugs and diseases, existing drugs can be applied more effectively to combat diseases. ReviveMed’s proprietary database and machine-learning algorithm reduces the need for time-consuming and costly experiments, predicts the identity of each metabolite mass, and integrates data with large-scale molecular datasets including genomics and proteomics. By identifying and understanding individual metabolites, ReviveMed’s technology allows scientists to discover detailed molecular pathways associated diseases and identify new therapeutic effects for existing drugs and drugs in development.
Investment: $1,500,000
Health Care, Biotechnology, Software, Medical Devices, Biotherapeutics, R&D, B2B